Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulipristal versus leuprorelin before laparoscopic myomectomy
NL-OMON45087Phase 4Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Jan 2015
- Modality
- Small Molecules, Peptides, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Fibromyoma (LM) comparing Ulipristal acetate + placebo injection with Leuprorelin + placebo tablets (2 arms). Primary endpoint: Total blood loss during laparoscopic myomectomy. Started Jan 2015; status: active, not recruiting.
02
Drugs
ulipristalleuprolide
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on NL-OMON45087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45087.